A subtype-selective, use-dependent inhibitor of native AMPA receptors

被引:27
|
作者
Nilsen, Aaron
England, Pamela M. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
关键词
D O I
10.1021/ja0705801
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AMPA (alpha-amino-3-hydroxy-5-methyl-4-isooxazole) receptors (AMPARs) are glutamate-gated ion channels that play central roles in the mammalian brain, mediating fast excitatory synaptic transmission and underlying several forms of synaptic plasticity. Two subtypes of AMPARs are primarily coexpressed at excitatory synapses in adult animals (GluR1/2 and GluR2/3 receptors). Efforts to distinguish between the potentially distinct roles these receptor subtypes play at synapses have been hampered by the absence of a subtype-selective AMPAR antagonist. Here we show that the polyamine philanthotoxin-7,4 (PhTx-74) is a subtype-selective AMPAR antagonist, inhibiting GluR1/2, but not GluR2/3 receptors, use-dependently. The molecular basis for the observed selectivity and a highly efficient synthesis of this remarkable toxin are also presented. PhTx-74 provides the first a means of directly monitoring subtype-specific changes in the composition of AMPARs at native synapses, including during hippocampal long-term potentiation (LTP), a form of synaptic plasticity thought to share processes related to learning and memory.
引用
收藏
页码:4902 / +
页数:3
相关论文
共 50 条
  • [1] Developing a complete pharmacology for AMPA receptors: A perspective on subtype-selective ligands
    Fleming, James J.
    England, Pamela M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (04) : 1381 - 1387
  • [2] Evaluation of PhTX-74 as Subtype-Selective Inhibitor of GluA2-Containing AMPA Receptors
    Poulsen, Mette H.
    Lucas, Simon
    Stromgaard, Kristian
    Kristensen, Anders S.
    [J]. MOLECULAR PHARMACOLOGY, 2014, 85 (02) : 261 - 268
  • [3] A tetrazolyl-substituted subtype-selective AMPA receptor agonist
    Vogensen, Stine B.
    Frydenvang, Karla
    Greenwood, Jeremy R.
    Postorino, Giovanna
    Nielsen, Birgitte
    Pickering, Darryl S.
    Ebert, Bjarke
    Bolcho, Ulrik
    Egebjerg, Jan
    Gajhede, Michael
    Kastrup, Jette S.
    Johansen, Tommy N.
    Clausen, Rasmus P.
    Krogsgaard-Larsen, Povl
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) : 2408 - 2414
  • [4] Subtype-selective antagonism of NMDA receptors by nylidrin
    Whittemore, ER
    Ilyin, VI
    Konkoy, CS
    Woodward, RM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 337 (2-3) : 197 - 208
  • [5] Use of subtype-selective antagonists to probe the NR2-dependent effects of acute and chronic ethanol on NMDA receptors
    Xu, M
    Carpenter-Hyland, E
    Chandler, LJ
    Woodward, JJ
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 140A - 140A
  • [6] Metabotropic glutamate receptors: structure and new subtype-selective ligands
    Pellicciari, R
    Costantino, G
    Marinozzi, M
    Macchiarulo, A
    Camaioni, E
    Natalini, B
    [J]. FARMACO, 2001, 56 (1-2): : 91 - 94
  • [7] Use-dependent regulation of GABAA receptors
    Barnes, Eugene M., Jr.
    [J]. INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 39, 1996, 39 : 53 - 76
  • [8] Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors
    Zeng, Yue
    Zheng, Yueming
    Zhang, Tongtong
    Ye, Fei
    Zhan, Li
    Kou, Zengwei
    Zhu, Shujia
    Gao, Zhaobing
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs
    Ilan Shimon
    [J]. Endocrine, 2003, 20 : 265 - 269
  • [10] Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs
    Shimon, I
    [J]. ENDOCRINE, 2003, 20 (03) : 265 - 269